Financials Nanosonics Limited

Equities

NAN

AU000000NAN9

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:05 2024-04-29 am EDT 5-day change 1st Jan Change
2.92 AUD +6.18% Intraday chart for Nanosonics Limited +3.91% -33.64%

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,686 2,050 1,770 1,014 1,433 833.2 - -
Enterprise Value (EV) 1 1,614 1,958 1,676 919.7 1,321 712.3 702.4 686.1
P/E ratio 125 x 205 x 209 x 275 x 73 x 94.5 x 62 x 43.2 x
Yield - - - - - - - -
Capitalization / Revenue 20 x 20.5 x 17.2 x 8.43 x 8.63 x 4.98 x 4.35 x 4.01 x
EV / Revenue 19.1 x 19.6 x 16.3 x 7.64 x 7.96 x 4.26 x 3.66 x 3.3 x
EV / EBITDA 91.5 x 121 x 110 x 122 x 49.3 x 55 x 32.5 x 22 x
EV / FCF 514 x 93.7 x 275 x -4,443 x 66.9 x 46.6 x 60.4 x 34 x
FCF Yield 0.19% 1.07% 0.36% -0.02% 1.5% 2.15% 1.66% 2.94%
Price to Book 15.3 x 16.7 x 13.1 x 7.31 x 8.75 x 4.71 x 4.4 x 4.01 x
Nbr of stocks (in thousands) 299,967 300,604 301,465 301,835 302,316 302,979 - -
Reference price 2 5.620 6.820 5.870 3.360 4.740 2.750 2.750 2.750
Announcement Date 8/26/19 8/24/20 8/23/21 8/22/22 8/21/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 84.32 100.1 103.1 120.3 166 167.3 191.7 208
EBITDA 1 17.64 16.23 15.19 7.509 26.77 12.95 21.6 31.16
EBIT 1 15.5 11.6 10.76 1.782 19.64 5.535 13.62 20.56
Operating Margin 18.38% 11.59% 10.44% 1.48% 11.83% 3.31% 7.1% 9.88%
Earnings before Tax (EBT) 1 16.83 12.4 10.98 1.578 21.6 8.488 16.76 25.55
Net income 1 13.6 10.1 8.578 3.742 19.88 8.601 13.58 19.4
Net margin 16.13% 10.09% 8.32% 3.11% 11.98% 5.14% 7.09% 9.32%
EPS 2 0.0449 0.0333 0.0281 0.0122 0.0649 0.0291 0.0444 0.0637
Free Cash Flow 1 3.142 20.9 6.087 -0.207 19.75 15.29 11.63 20.19
FCF margin 3.73% 20.88% 5.91% -0.17% 11.9% 9.14% 6.07% 9.7%
FCF Conversion (EBITDA) 17.81% 128.75% 40.08% - 73.76% 118.1% 53.84% 64.79%
FCF Conversion (Net income) 23.1% 206.93% 70.96% - 99.32% 177.75% 85.6% 104.08%
Dividend per Share 2 - - - - - - - -
Announcement Date 8/26/19 8/24/20 8/23/21 8/22/22 8/21/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 48.5 51.6 43.1 59.98 60.65 59.67 81.6 84.39 79.6 86.7 - -
EBITDA 8.238 7.995 2.062 13.13 5.79 1.719 - 13.93 6.805 - - -
EBIT 1 6.303 5.297 - 10.76 3.351 -1.569 10.7 8.935 3 2.6 - -
Operating Margin 13% 10.27% - 17.94% 5.53% -2.63% 13.11% 10.59% 3.77% 3% - -
Earnings before Tax (EBT) - 5.657 0.2 10.78 3.261 -1.683 11.4 - 4.9 - - -
Net income 5.711 4.4 1.5 7.114 3.875 -0.133 10.4 9.483 6.2 - - -
Net margin 11.78% 8.53% 3.48% 11.86% 6.39% -0.22% 12.75% 11.24% 7.79% - - -
EPS 2 0.0188 - 0.004800 0.0233 0.0127 -0.000500 0.0340 0.0309 0.0202 0.0200 0.0200 0.0300
Dividend per Share - - - - - - - - - - - -
Announcement Date 2/25/20 8/24/20 2/23/21 8/23/21 2/21/22 8/22/22 2/22/23 8/21/23 2/25/24 - - -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 71.7 91.7 93.5 94.5 112 121 131 147
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 3.14 20.9 6.09 -0.21 19.7 15.3 11.6 20.2
ROE (net income / shareholders' equity) 13.3% 8.65% 6.6% 2.73% 13.1% 5.13% 6.81% 9.03%
ROA (Net income/ Total Assets) 11.4% 7.33% 5.55% 2.14% 9.77% 3.28% 5.06% 8.31%
Assets 1 119.4 137.8 154.7 175 203.5 261.9 268.3 233.4
Book Value Per Share 2 0.3700 0.4100 0.4500 0.4600 0.5400 0.5800 0.6300 0.6900
Cash Flow per Share 2 0.0200 0.0800 0.0200 0.0200 0.0800 0.0500 0.0700 0.0900
Capex 1 1.68 1.88 1.23 6.79 3.57 3.36 4.29 4.5
Capex / Sales 2% 1.88% 1.19% 5.64% 2.15% 2.01% 2.24% 2.16%
Announcement Date 8/26/19 8/24/20 8/23/21 8/22/22 8/21/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2.75 AUD
Average target price
3.204 AUD
Spread / Average Target
+16.52%
Consensus
  1. Stock Market
  2. Equities
  3. NAN Stock
  4. Financials Nanosonics Limited